Specialty Pharmacy

The disease burden of smoking remains immense despite widespread tobacco cessation efforts.

SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses MedImpact's Centers of Excellence program.

Pharmacy Times and Specialty Pharmacy Times add several new organizations to Strategic Alliance Partnership programs.

Nearly 700 children across 46 states are now infected with the severe respiratory illness.

Palbociclib provides first-line systemic treatment for women with advanced or metastatic breast cancer.

Investigators are working to resolve how a health care worker in Texas contracted the Ebola virus while caring for an infected patient.

Investigational bispecific T-cell engager antibody construct aids immune system in targeting cancer cells.

Diplomat Pharmacy, Inc, the nation's largest independent specialty pharmacy began trading its common stock the NYSE on October 10 in connection with its IPO.

Five US airports that receive the majority of travelers from West African nations will add new layers of entry screening.

In a retrospective study, investigators found that increases in total cholesterol and triglycerides were associated with an increased risk of biochemical recurrence in prostate cancer.

Provides use, cost forecast based on testing, future treatment rates.

The FDA today approved Gilead's Harvoni, the first combination pill to treat chronic hepatitis C virus genotype 1 infection.

The drug combination prevents nausea and vomiting after the start of cancer chemotherapy.

Brand name, patent-protected medications drive increasing costs.

Researcher urges caution in prescribing testosterone therapy in men who have not been diagnosed with hypogonadism.

Virus was undetectable for 3 years before researchers discovered viral reservoirs have not disappeared.

World Health Organization officials are stressing that clinical trials on Ebola vaccine candidates need to be expedited.

Howard Barsky, chief information officer for Armada Health Care, discusses how specialty pharmacies can improve services for patients through the use of data analytics.

Researchers in Finland are learning more about how hormones influence the risk of developing breast cancer, which may lead to a hormone-based treatment to reduce the risk of developing cancer later in life.

The child showed no symptoms of the respiratory virus prior to his death.

Findings of study provide new options for future vaccine development.

Authorities are homing in on those who may have been in contact with a Liberian national who traveled to Dallas while infected with the Ebola virus.

Patients who smoke both traditional and e-cigarettes less likely to quit than those who only smoke traditional cigarettes.

Sleep disorders may require independent diagnosis and management, researchers say.

Study finds stringent eligibility criteria is creating a barrier for patient enrollment.

Texas health care officials have ordered close relatives of the Dallas Ebola patient to stay home.

Investigators aim to reduce side effects of therapy with sofosbuvir in children with hepatitis C.

Evolocumab cut low-density lipoprotein cholesterol levels by 60%, on average, in patients with heterozygous familial hypercholesterolemia

Gilead has refined the pharmacokinetics of tenofovir disoproxil fumarate (TDF), an anchor drug in several single-tablet medications for HIV-1, to create tenofovir alafenamide (TAF). Phase II results indicate superior renal outcomes and equivalent clinical outcomes with TAF versus TDF.